Company Filing History:
Years Active: 1986
Title: Innovator Friedmund Numann: Pioneering Prostate Treatment Solutions
Introduction: Friedmund Numann is an influential inventor based in Berlin, Germany, known for his significant contributions to medical science, particularly in the field of urology. With a focus on improving therapeutic methods for prostatic hyperplasia, Numann has successfully secured a patent that showcases his innovative approach to this common medical condition.
Latest Patents: Numann holds a noteworthy patent for "Combinations of an aromatase-inhibitor and an antiandrogen." This invention presents a combination of an aromatase-inhibitor and an antiandrogen in a specific weight ratio ranging from 20:1 to 1:1. The clinical application of this combination aims to provide effective prophylaxis and treatment of prostatic hyperplasia. The patent specifically mentions testolactone as the aromatase-inhibitor and cyproterone acetate as the antiandrogen, highlighting the potential for significant advances in treatment methodologies.
Career Highlights: Throughout his professional journey, Friedmund Numann has worked with prominent organizations and has made substantial contributions to pharmaceutical research and development. His work at Schering Aktiengesellschaft has notably positioned him at the forefront of exploring new therapeutic avenues for enhancing patient care in urological health.
Collaborations: Numann's inventive journey has been enriched by collaborations with esteemed colleagues such as Hans-Udo Schweikert and Ulf Tunn. These associations have fostered a creative environment that has enabled Numann to successfully conceptualize and develop his innovative patent.
Conclusion: Friedmund Numann exemplifies the spirit of innovation in the medical field, particularly regarding the treatment of prostatic hyperplasia. His patent represents not only a personal achievement but also a valuable contribution to the healthcare landscape. As medical research evolves, the continued exploration of such innovative solutions will play a crucial role in improving patient outcomes in urology.